Halozyme (HALO) Debt/EBITDA US GAAP (year values) |
|||||||||
2020 | 2021 | 2022 | 2022 | 2023 | LTM ? | CAGR 5 years ? | |||
Debt/EBITDA | 0.19 | 0.52 | 3.62 | 3.62 | 2.57 | 1.47 | |||
Changes by years, y/y, % | -42% | +174% | +591% | 0% | -29% | -4.8% |
Halozyme. Debt/EBITDA
Halozyme. Debt/EBITDA, changes, %
Halozyme (HALO) Debt/EBITDA US GAAP (quarter values) |
||||||||
2023Q3 | 2023Q4 | 2024Q1 | 2024Q2 | 2024Q3 | LTM ? | |||
Debt/EBITDA | 2.57 | 2.63 | 2.19 | 1.97 | 1.47 | 1.47 | ||
Changes by years, y/y, % | -39% | -28% | -44% | -35% | -43% | |||
Changes by quarters, q/q, % | -15% | +2% | -16% | -10% | -25% |